PCRX — Pacira BioSciences, Inc.

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Pacira BioSciences, Inc.

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and kne… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$24.04
Market Cap$924M
Float33.7M
Shares Outstanding39.3M
P/E (Forward)7.62
P/E (TTM)180.62
Price/Sales (TTM)1.23
vs. Analyst Target+21.8% to analyst PT
Profit Margin0.70%
Operating Margin (TTM)2.61%
Revenue (TTM)$735M
Earnings Growth (YoY)-30.00%
Dividend RateNone
Analyst Target Price$29.29 (7 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $430M $146M $312M $63.5M
2021 $542M $42.0M $401M $114M
2022 $667M $15.9M $468M $140M
2023 $675M $42.0M $490M $155M
2024 $701M -$99.6M $531M $29.1M
2025 $726M $7.0M $577M $123M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $181M -$4.8M
Sep 2025 $180M $5.4M
Dec 2025 $197M $1.6M
Mar 2026 $177M $2.9M

Ownership & Float

Insider Ownership1.7%
Institutional Ownership115.5%
Short Float23.1%
% of All Funds Holding2.70%
Number of Funds Holding222

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$23.62Near-term / short-term trend
Weekly40-Week SMA$23.52Medium-term trend
Weekly80-Week SMA$23.43Cyclical trend (business cycle)
Weekly200-Week SMA$29.97Secular trend (multi-year)
Monthly10-Month SMA$23.79Near-term monthly trend
Monthly20-Month SMA$23.16Medium-term monthly trend
Monthly40-Month SMA$27.24Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$26.00 resistance 1.34x 3 months ago
$28.70 resistance 2.28x 21 months ago

Historical Earnings Reactions (61 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.26% 0.25% 57.38% 13.56% -7.67%
1 Day 0.64% 0.19% 55.74% 11.84% -9.57%
1 Week 1.33% 1.84% 60.66% 14.28% -26.36%
2 Weeks 0.23% 0.71% 52.46% 24.76% -36.18%
1 Month 4.23% 5.00% 60.00% 49.15% -20.37%

Next earnings: July 19, 2026 (52 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan5.0%60.0%15
Feb2.5%66.7%15
Mar-0.3%50.0%16
Apr4.6%62.5%16
May2.2%53.3%15
Jun1.3%40.0%15
Jul-3.2%40.0%15
Aug1.7%53.3%15
Sep-1.2%33.3%15
Oct-2.8%26.7%15
Nov6.6%73.3%15
Dec4.2%60.0%15

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.09% 47.8% 720
Tuesday 0.21% 52.8% 792
Wednesday 0.14% 49.9% 788
Thursday -0.03% 49.7% 774
Friday 0.17% 52.5% 774

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 115.5%

Insider Transactions — Smart Summary

Total insider ownership: 1.7%

12-Month Insider Activity Summary

Total Filings14
Net Value-$2.4M
Net Shares Change-95,134
% of Float-0.3%
C-Suite Filings11
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
WILLIAMS KRISTEN Chief Administrative Officer -$1.2M 2 1 sell
RIKER LAUREN Senior Vice President, Finance -$413,240.28 3 1 sell
Cross Shawn Chief Financial Officer -$266,405.4 1 N/A
BIGAL MARCELO -$116,267.04 1 1 sell
SLONIN JONATHAN Chief Medical Officer -$95,396.4 1 N/A
Ceesay Abraham -$64,005.26 1 N/A
Froimson Mark -$10,905 1 1 sell

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-03-19 Froimson Mark -$10,905 Transaction at $21.81, now +10.2%
2025-06-05 WILLIAMS KRISTEN Chief Administrative Officer -$539,903.04 Transaction at $26.32, now -8.7%
2025-06-05 RIKER LAUREN Senior Vice President, Finance -$235,281.76 Transaction at $26.30, now -8.6%
2025-08-11 BIGAL MARCELO -$116,267.04 Transaction at $23.67, now +1.6%
2026-02-03 WILLIAMS KRISTEN Chief Administrative Officer -$621,634.97 Transaction at $20.54, now +17.1%
2026-02-03 RIKER LAUREN Senior Vice President, Finance -$139,745.54 Transaction at $20.67, now +16.3%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Pacira BioSciences, Inc. (PCRX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for PCRX on Trend Edge →